RGO TENSION UP SERUM

Manufacturer
SugarEn Co., Ltd.
Effective date
2021-05-29
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:41:27

Label at a glance#

ProductRGO TENSION UP SERUM
Active ingredientNIACINAMIDE, ADENOSINE
Label structure12 sections

Dosage and administration

Apply an appropriate amount onto the entire face, and gently pat for better absorption.

Storage and handling

Do not store in direct sunlight.

Label contents#

Full prescribing information#

Active ingredient(s)

OTC - ACTIVE INGREDIENT SECTION

Niacinamide 2.0%

Adenosine 0.04%

Purpose

OTC - PURPOSE SECTION

Skin Brightening, Anti-wrinkle

Use(s)

DOSAGE & ADMINISTRATION SECTION

Helps brighten skin and anti wrinkle.

Improves skin vitality and elasticity.

Warnings

WARNINGS SECTION

For external only.

When using this product,

OTC - WHEN USING SECTION

keep out of eyes and mouth.

Do not use

OTC - DO NOT USE SECTION

on damaged or broken skin.

Stop use and ask a doctor

OTC - STOP USE SECTION

if irritation or rashes occurs.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

Other information

STORAGE AND HANDLING SECTION

Do not store in direct sunlight.

Directions

INDICATIONS & USAGE SECTION

Apply an appropriate amount onto the entire face, and gently pat for better absorption.

Inactive indredients

INACTIVE INGREDIENT SECTION

Water, Pentylene Glycol, 1,2-Hexanediol, Glycerin, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Sodium Hyaluronate, PEG-60 Hydrogenated Castor Oil, Panthenol, Allantoin, Ammonium Acryloyldimethyltaurate/VP Copolymer, Panax Ginseng Root Extract, Polysorbate 60, Sorbitan Isostearate, Disodium EDTA, Fragrance, Beta-Glucan, t-Butyl Alcohol, Ethylhexylglycerin, Limonene, Linalool

Package Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

81897-50281897-502

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ADENOSINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d676a241-be05-4740-b3ee-1a5f2ed422d2Product name420180615
dd8bd48f-20d6-43c7-b471-3ae872868afaProduct name320180125
d41954ff-bc63-4b2c-aba0-9146707659d7Product name220151117

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
81897-502-012022-07-29C16284748780-1e4f33bdf-9b4b-d8a0-e053-dadaa90a6e4e81897-502 RGO TENSION UP SERUM

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
81897-502-01RGO TENSION UP SERUM50 mL in 1 BOTTLE, PLASTICLIQUID501

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
81897-502RGO TENSION UP SERUM (NIACINAMIDE, ADENOSINE) LIQUID [SUGAREN CO., LTD.]1Legacy NDC, 1 package rows20210714_c3759036-4678-f906-e053-2995a90ae5c1.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 22 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
81897-50281897-502-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
c3759036-4679-f906-e053-2995a90ae5c1c3759036-4678-f906-e053-2995a90ae5c12021-05-29WarningsExact identifier
spl id: c3759036-4679-f906-e053-2995a90ae5c1
spl set id: c3759036-4678-f906-e053-2995a90ae5c1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.